within Pharmacolibrary.Drugs.ATC.R;

model R07AA02
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.1,
    Cl             = 0.02 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 100 / 1000000,
    adminCount     = 1,
    Vd             = 5e-05,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Natural phospholipids are generally purified mixtures of phospholipids, often derived from sources such as egg yolk or soybean lecithin. They are primarily used as surfactants in therapy for respiratory distress syndrome and as excipients in drug formulations. Their clinical usage as active drugs is limited, but in the context of respiratory system drugs (ATC code R07AA02), they are indicated for treating neonatal respiratory distress syndrome by intratracheal administration. They are not typically considered as active pharmaceutical ingredients for systemic therapeutic effect.</p><h4>Pharmacokinetics</h4><p>No clinical pharmacokinetic studies in humans with systemic administration of natural phospholipids as active drug are available. No published human PK data exists for this ATC code. The following is an estimated one-compartment PK model based on physicochemical expectations and general absorption/distribution properties for phospholipids.</p><h4>References</h4><ol><li><p>Rider, ED, et al., &amp; Jobe, AH (2000). Lysosomes from rabbit type II cells catabolize surfactant lipids. <i>American journal of physiology. Lung cellular and molecular physiology</i> 278(1) L68–L74. DOI:<a href=&quot;https://doi.org/10.1152/ajplung.2000.278.1.L68&quot;>10.1152/ajplung.2000.278.1.L68</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/10645892/&quot;>https://pubmed.ncbi.nlm.nih.gov/10645892</a></p></li><li><p>Jacobs, HC, et al., &amp; Mercurio, MR (1988). Reutilization of surfactant phosphatidylglycerol and lysophosphatidylcholine by adult rabbits. <i>Biochimica et biophysica acta</i> 962(2) 227–233. DOI:<a href=&quot;https://doi.org/10.1016/0005-2760(88)90164-6&quot;>10.1016/0005-2760(88)90164-6</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3167080/&quot;>https://pubmed.ncbi.nlm.nih.gov/3167080</a></p></li><li><p>Zhao, YZ, et al., &amp; Yang, W (2011). An in vivo experiment to improve pulmonary absorption of insulin using microbubbles. <i>Diabetes technology &amp; therapeutics</i> 13(10) 1013–1021. DOI:<a href=&quot;https://doi.org/10.1089/dia.2011.0113&quot;>10.1089/dia.2011.0113</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/21745138/&quot;>https://pubmed.ncbi.nlm.nih.gov/21745138</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end R07AA02;
